Eukles Asset Management Baxter International Inc Transaction History

Eukles Asset Management

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$74.57 - $87.19 $196,491 - $229,745	-2,635 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$73.77 - $83.61 $74,950 - $84,947	1,016 Added 62.75%	2,635 $212,000
Q2 2021 Jul 27, 2021	BUY	$80.5 - $88.01 $100,625 - $110,012	1,250 Added 338.75%	1,619 $130,000
Q1 2021 Apr 27, 2021	BUY	$76.38 - $86.03 $1,909 - $2,150	25 Added 7.27%	369 $31,000
Q4 2020 Jan 26, 2021	BUY	$75.39 - $82.36 $1,055 - $1,153	14 Added 4.24%	344 $28,000
Q3 2020 Oct 29, 2020	BUY	$78.33 - $90.73 $4,621 - $5,353	59 Added 21.77%	330 $27,000
Q2 2020 Jul 29, 2020	BUY	$78.66 - $94.14 $2,359 - $2,824	30 Added 12.45%	271 $23,000
Q1 2020 Apr 22, 2020	BUY	$71.57 - $93.3 $930 - $1,212	13 Added 5.7%	241 $20,000
Q4 2019 Jan 24, 2020	BUY	$76.7 - $88.45 $306 - $353	4 Added 1.79%	228 $19,000
Q3 2019 Oct 29, 2019	BUY	$81.4 - $89.78 $4,884 - $5,386	60 Added 36.59%	224 $20,000
Q2 2019 Aug 01, 2019	BUY	$73.44 - $82.41 $3,304 - $3,708	45 Added 37.82%	164 $13,000
Q1 2019 Apr 23, 2019	BUY	$64.48 - $81.31 $5,158 - $6,504	80 Added 205.13%	119 $10,000
Q4 2018 Jan 22, 2019	BUY	$61.45 - $77.8 $2,396 - $3,034	39 New	39 $3,000

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Eukles Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eukles Asset Management with notifications on news.